Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout

Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout

During the first months after initiation of urate-lowering therapy in patients with gout, the risk of exacerbating arthritis substantially increases, frequently causing them to refuse this treatment. The main way to avoid this risk is the preventive administration of colchicine, nonsteroidal anti-in...

Full description

Bibliographic Details
Main Author:	M. N. Chikina
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2019-01-01
Series:	Научно-практическая ревматология
Subjects:	gout prevention urate-lowering therapy
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2654

Similar Items

Impact of urate-lowering therapy on quality of life indicators in patients with gout
by: M. N. Chikina, et al.
Published: (2021-06-01)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
by: Aung T, et al.
Published: (2017-04-01)

Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy
by: J. Chen, et al.
Published: (2021-04-01)

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
by: Fu-Shun Yen, et al.
Published: (2020-02-01)

Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
by: Huai Leng Pisaniello, et al.
Published: (2018-07-01)

Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
by: Matthew Roughley, et al.
Published: (2018-10-01)

Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01)

Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
by: Panagiota Drivelegka, et al.
Published: (2018-06-01)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
by: Zijing Ran, et al.
Published: (2021-09-01)

Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
by: Nan Liang, et al.
Published: (2019-09-01)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
by: Dalbeth Nicola, et al.
Published: (2012-09-01)

A single-centre experience of febuxostat as a second-line urate-lowering therapy
by: Swee Gaik Ong, et al.
Published: (2021-01-01)

Guideline development for the management of gout: role of combination therapy with a focus on lesinurad
by: Jones G, et al.
Published: (2017-10-01)

Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort
by: Laura Ranieri, et al.
Published: (2018-03-01)

Association Between Gout and Injury Risk: A National Retrospective Cohort Study
by: Shih-Hsiang Ou, et al.
Published: (2020-05-01)

The impact of urate-lowering therapy on kidney function (IMPULsKF)
by: D.D. Ivanov
Published: (2017-04-01)

Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
by: Brian F. Mandell, et al.
Published: (2018-12-01)

Difficulties and Mistakes in the Management of the Patient with Gout
by: S.A. Trypilka, et al.
Published: (2016-10-01)

Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
by: Ting-Ting Chung, et al.
Published: (2019-09-01)

Utility of the Morisky Medication Adherence Scale in gout: a prospective study
by: Tan CSL, et al.
Published: (2016-12-01)

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
by: Ravi K. Narang, et al.
Published: (2019-01-01)

Impact of pegloticase on patient outcomes in refractory gout: current perspectives
by: Cunha RN, et al.
Published: (2018-10-01)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
by: Puja Khanna, et al.
Published: (2020-10-01)

The relationship between ferritin and urate levels and risk of gout
by: Tahzeeb Fatima, et al.
Published: (2018-08-01)

Practical application of national clinical guidelines for the management of gout (preliminary data)
by: M. N. Chikina, et al.
Published: (2020-05-01)

Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
by: A. P. Kuzmina, et al.
Published: (2019-01-01)

Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016
by: Man Fung Tsoi, et al.
Published: (2020-09-01)

A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout
by: Stephen P. Juraschek, et al.
Published: (2021-02-01)

The role of assessment of quality of life and health with the index of vital activity in patients with arterial hypertension combined with gout in the family doctor practice.
by: O. M. Lazarenko, et al.
Published: (2018-05-01)

Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
by: V. I. Mazurov, et al.
Published: (2020-12-01)

Arterial hypertension and gout: the current state of the problem (literature review).
by: A. P. Kuzmina, et al.
Published: (2017-12-01)

UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01)

Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice
by: Kateryna Pierzynowska, et al.
Published: (2020-11-01)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)

Gout Is Prevalent but Under-Registered Among Patients With Cardiovascular Events: A Field Study
by: Irene Calabuig, et al.
Published: (2020-09-01)

The Role of a “Treat-to-Target” Approach in the Long-Term Renal Outcomes of Patients with Gout
by: Woo-Joong Kim, et al.
Published: (2019-07-01)

Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis
by: Philip C. Robinson, et al.
Published: (2021-08-01)

Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
by: Mengying Sun, et al.
Published: (2018-05-01)

Gout is not associated with the risk of fracture: a meta-analysis
by: Fanxiao Liu, et al.
Published: (2019-08-01)

Uric acid transporter inhibitors for gout
by: Philip K. Tan, et al.
Published: (2017-06-01)

Cannot write session to /tmp/vufind_sessions/sess_jk2uuc174e1irnfpdef75m2sv9